Open Access
Table 2
IgG titers, IB-recomLine sensitivity, specificity and overall agreement between IB-recomLine and other assays.
Serum group (number of sera) | ELISA mean IgG levels ± SD (IU/mL) |
IB-recomLine sensitivity (%) [95% CI] |
IB-recomLine specificity (%) [95% CI] |
IgG overall agreement (%) (kappa value) between IB-recomLine and other assays | ||||||
---|---|---|---|---|---|---|---|---|---|---|
ARCHITECT | VIDAS | Equivocal IB results = negative | Equivocal IB results = positive | Equivocal IB results = negative | Equivocal IB results = positive | ARCHITECT | VIDAS | WB-LDBIO | ||
Negative | <1.6 | <4 | ||||||||
Equivocal | [1.6–2.9] | [4–7] | ||||||||
Positive | ≥3 | ≥8 | ||||||||
1 (n = 50) | 51.4 ± 112.1 | 95.1 ± 102.9 | 97.1 [84.7–99.9] | 100 [89.7–100] | 100 [79.4–100] | 93.8 [69.8–99.8] | 94 (0.87) | 90 (0.8) | NP | |
2 (n = 47) | 2.9 ± 3.5 | 6.7 ± 2.8 | 58.1 [39.1–75.5] | 77.4 [58.9–90.4] | 87.5 [61.7–98.5] | 50 [24.7–75.4] | NP | NP | 55.3 (0.27) |
SD: standard deviation; CI: confidence interval; NP: not performed
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.